Basic Information
RNALocate ID: RLID:01002541
RNA Symbol: hsa-miR-454-3p
Localization: Nucleus
RNA Information
RNA Name: hsa-miR-454
RNA ID: miRBase:MIMAT0003885
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 24918059
Tissue/Cell Line: Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa)
Method: Microarray
Description: Data are collected from supplementary Table S2. MiRNA reads in the subcellular fractions.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01002540 Cytoplasm Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01002542 Nucleolus HeLa cells 23940654
RLID:11003516 Exosome Serum 18589210
RLID:11003517 Exosome Saliva 19627513
RLID:11003518 Exosome Breast cancer cell line (MCF-7) 20976003
RLID:11003519 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11003520 Exosome Plasma 23663360
RLID-D:11000174 Exosome Endothelial cells
RLID-D:11000559 Microvesicle Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-454-3p Multiple sclerosis chronic progressive MNDR-E-MI-51582
MNDR hsa-miR-454-3p Oral squamous cell carcinoma MNDR-E-MI-51583
MNDR hsa-miR-454-3p Uterine corpus endometrial carcinoma MNDR-E-MI-51584
MNDR hsa-miR-454-3p Lymphoma MNDR-E-MI-51585
MNDR hsa-miR-454-3p Estrogen-receptor positive breast cancer MNDR-E-MI-51586
MNDR hsa-miR-454-3p Estrogen-receptor negative breast cancer MNDR-E-MI-51587
MNDR hsa-miR-454-3p Progesterone-receptor positive breast cancer MNDR-E-MI-51588
MNDR hsa-miR-454-3p Progesterone-receptor negative breast cancer MNDR-E-MI-51589
MNDR hsa-miR-454-3p Her2-receptor positive breast cancer MNDR-E-MI-51590
MNDR hsa-miR-454-3p Breast cancer luminal MNDR-E-MI-51591
MNDR hsa-miR-454-3p Prostate cancer MNDR-E-MI-51592
MNDR hsa-miR-454-3p Gastric cancer MNDR-E-MI-51593
MNDR hsa-miR-454-3p Alzheimer disease MNDR-E-MI-51594
MNDR hsa-miR-454-3p Intracranial aneurysm MNDR-E-MI-51595
MNDR hsa-miR-454-3p Dysautonomia familial MNDR-E-MI-51596
MNDR hsa-miR-454-3p Myotonic dystrophy MNDR-E-MI-51597
MNDR hsa-miR-454-3p Seizures MNDR-E-MI-51598
MNDR hsa-miR-454-3p Leukemia MNDR-E-MI-51599
MNDR hsa-miR-454-3p Cardiovascular disease MNDR-E-MI-51600
MNDR hsa-miR-454-3p Lung cancer MNDR-E-MI-51601
MNDR hsa-miR-454-3p Parkinson disease MNDR-E-MI-51602
MNDR hsa-miR-454-3p Basal-like breast cancer MNDR-E-MI-51603
MNDR hsa-miR-454-3p Pancreatic cancer MNDR-E-MI-51604
MNDR hsa-miR-454-3p Melanoma MNDR-E-MI-51605
MNDR hsa-miR-454-3p Nephroblastoma MNDR-E-MI-51606
MNDR hsa-miR-454-3p Colon cancer MNDR-E-MI-51607
MNDR hsa-miR-454-3p Ischemic attack transient MNDR-E-MI-51608
MNDR hsa-miR-454-3p Colon adenocarcinoma MNDR-E-MI-51609
MNDR hsa-miR-454-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-51610
MNDR hsa-miR-454-3p Ovarian cancer MNDR-E-MI-51611
MNDR hsa-miR-454-3p Prostate adenocarcinoma MNDR-E-MI-51612
MNDR hsa-miR-454-3p Carcinoma ductal breast MNDR-E-MI-51613
MNDR hsa-miR-454-3p Glioblastoma MNDR-E-MI-51614
MNDR hsa-miR-454-3p Glioma MNDR-E-MI-51615
MNDR hsa-miR-454-3p Amyotrophic lateral sclerosis MNDR-E-MI-51616
MNDR hsa-miR-454-3p Breast carcinoma MNDR-E-MI-51617
MNDR hsa-miR-454-3p Bone-invasive pituitary adenoma MNDR-E-MI-51618
MNDR hsa-miR-454-3p Lung squamous cell carcinoma MNDR-E-MI-51619
MNDR hsa-miR-454-3p Non-small cell lung adenocarcinoma MNDR-E-MI-51620
MNDR hsa-miR-454-3p Lung adenocarcinoma MNDR-E-MI-51621
MNDR hsa-miR-454-3p Bladder urothelial carcinoma MNDR-E-MI-51622
MNDR hsa-miR-454-3p Pancreatic adenocarcinoma MNDR-E-MI-51623
MNDR hsa-miR-454-3p Cervical cancer MNDR-E-MI-51624
MNDR hsa-miR-454-3p Kidney renal clear cell carcinoma MNDR-E-MI-51625
MNDR hsa-miR-454-3p Renal carcinoma MNDR-E-MI-51626
MNDR hsa-miR-454-3p Kidney renal papillary cell carcinoma MNDR-E-MI-51627
MNDR hsa-miR-454-3p Renal clear cell carcinoma MNDR-E-MI-51628
MNDR hsa-miR-454-3p Intrahepatic cholangiocarcinoma MNDR-E-MI-51629
MNDR hsa-miR-454-3p Cholangiocarcinoma MNDR-E-MI-51630
MNDR hsa-miR-454-3p Esophageal cancer MNDR-E-MI-51631
MNDR hsa-miR-454-3p Lung small cell carcinoma MNDR-E-MI-51632
MNDR hsa-miR-454-3p Synovial sarcoma MNDR-E-MI-51633
MNDR hsa-miR-454-3p Head and neck squamous cell carcinoma MNDR-E-MI-51634
MNDR hsa-miR-454-3p Breast invasive carcinoma MNDR-E-MI-51635
MNDR hsa-miR-454-3p Hepatocellular carcinoma MNDR-E-MI-51636
MNDR hsa-miR-454-3p B-cell lymphoma MNDR-E-MI-51637
MNDR hsa-miR-454-3p Rheumatoid arthritis MNDR-E-MI-51638
MNDR hsa-miR-454-3p Malignant pleural mesothelioma MNDR-E-MI-51639
MNDR hsa-miR-454-3p Hodgkin lymphoma MNDR-E-MI-51640
MNDR hsa-miR-454-3p Neuromyelitis optica MNDR-E-MI-51641
MNDR hsa-miR-454-3p Colorectal cancer MNDR-E-MI-51642
MNDR hsa-miR-454-3p Nasopharynx carcinoma MNDR-E-MI-51643
MNDR hsa-miR-454-3p Multiple myeloma MNDR-E-MI-51644
MNDR hsa-miR-454-3p Nasopharyngeal cancer MNDR-E-MI-51645
MNDR hsa-miR-454-3p Prostatic neoplasms MNDR-E-MI-51646
MNDR hsa-miR-454-3p Cerebral hemorrhage traumatic MNDR-E-MI-51647
MNDR hsa-miR-454-3p Stroke lacunar MNDR-E-MI-51648
MNDR hsa-miR-454-3p Breast cancer her3+ negative MNDR-E-MI-51649
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter CCDC6 Homo sapiens RR00291340
TOP